Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
120.50
-1.47 (-1.21%)
At close: Mar 25, 2025, 4:00 PM
120.51
+0.01 (0.01%)
After-hours: Mar 25, 2025, 4:53 PM EST
Agilent Technologies Market Cap
Agilent Technologies has a market cap or net worth of $34.35 billion as of March 25, 2025. Its market cap has decreased by -21.49% in one year.
Market Cap
34.35B
Enterprise Value
36.43B
1-Year Change
-21.49%
Ranking
Category
Stock Price
$120.50
Market Cap Chart
Since November 18, 1999, Agilent Technologies's market cap has increased from $19.58B to $34.35B, an increase of 75.46%. That is a compound annual growth rate of 2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 34.77B | -9.36% |
| Dec 31, 2024 | 38.37B | -5.82% |
| Dec 29, 2023 | 40.74B | -8.06% |
| Dec 30, 2022 | 44.31B | -8.10% |
| Dec 31, 2021 | 48.21B | 32.61% |
| Dec 31, 2020 | 36.36B | 37.40% |
| Dec 31, 2019 | 26.46B | 23.15% |
| Dec 31, 2018 | 21.49B | -0.67% |
| Dec 29, 2017 | 21.63B | 47.57% |
| Dec 30, 2016 | 14.66B | 5.55% |
| Dec 31, 2015 | 13.89B | 1.17% |
| Dec 31, 2014 | 13.73B | -27.66% |
| Dec 31, 2013 | 18.98B | 33.22% |
| Dec 31, 2012 | 14.24B | 17.14% |
| Dec 30, 2011 | 12.16B | -15.56% |
| Dec 31, 2010 | 14.40B | 32.87% |
| Dec 31, 2009 | 10.84B | 97.00% |
| Dec 31, 2008 | 5.50B | -59.69% |
| Dec 31, 2007 | 13.65B | -3.81% |
| Dec 29, 2006 | 14.19B | -13.76% |
| Dec 30, 2005 | 16.45B | 40.21% |
| Dec 31, 2004 | 11.73B | -15.73% |
| Dec 31, 2003 | 13.92B | 65.99% |
| Dec 31, 2002 | 8.39B | -35.63% |
| Dec 31, 2001 | 13.03B | -47.46% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 776.83B |
| UnitedHealth Group | 472.45B |
| Johnson & Johnson | 393.50B |
| AbbVie | 369.26B |
| Novo Nordisk | 335.17B |
| Merck & Co. | 233.18B |
| AstraZeneca | 229.25B |
| Abbott Laboratories | 220.62B |